Sensus Superficial Radiation Cures 98.9% Of Non-Melanoma Skin Cancer In Study

Sensus announced top-line results from a five-year restrospective study of its SRT-100 Superficial Radiation Therapy device for non-melanoma skin cancer. SRT-100 received a 510(k) in 2018.